Professional Documents
Culture Documents
Meeting Program
cytopathologymeeting.org
Be Sure it's the right choice for her
New study confirms1 using BD SurePath™ identifies more precursor lesions
leading to fewer missed cases of cervical cancer
19%
reduced risk
of invasive
15%
increased risk
cervical of invasive
cancer cervical
cancer
Please visit BD at booth 111 to learn more about this new study
Reference: 1. Previous Studies: Fremont-Smith M, et al. Comparison of the SP liquid-based Pap smear with the conventional Pap smear in a multisite
direct-to-vial study. Cancer. 2004; Kirsten Rozemeijer et al. Comparing SurePath, ThinPrep, and conventional cytology as primary test
method: SurePath is associated with increased CIN II+ detection rates Cancer Causes Control DOI 10.1007/s10552-015-0678-1
bd.com
ThinPrep is a registered trademark of Hologic, Inc. © 2017 BD. BD, the BD Logo and SurePath
are trademarks of Becton, Dickinson and Company. August 2017 Printed in the U.S.A.
2/C
Welcome
Please Note: Pre-registration is recommended. If you register onsite, handouts will not be available until after the meeting.
Schedule at a Glance
4:00 pm – 5:30 pm
7:30 am – 9:30 am Virtual Slide Seminar 4 Workshop 12
*9:00 am – 9:30 am Papanicolaou Address *5:30 pm – 6:30 pm ASC Business Meeting &
Awards Presentation
Sign-out with the
9:30 am – 10:30 am Professor 10 ASC Foundation
7:00 pm – 9:30 pm
Poster Presentations/ Reception
*9:30 am – 10:30 am Exhibit Hall Break
Monday, November 13, 2017
Non-Microscopic
9:30 am – 11:00 am Workshop 9 7:00 am – 8:00 am Trainee Enrichment 3
10:00 am – 12:00 pm Microscopic Workshop 5
Non-Microscopic
10:00 am – 12:00 pm Virtual Slide Seminar 5 8:00 am – 9:30 am Workshop 10
The Evolution of Diagnostic Cytology
*10:30 am – 11:00 am Cytopathology Practice *8:00 am – 9:30 am
Seminar
10:30 am – 12:00 pm Video Microscopy
Tutorial 8 *9:30 am – 10:00 am Refreshment Break
*11:00 am – 12:00 pm Leopold Koss Lecture *10:00 am – 11:00 am Diagnostic Cytology
Seminar (Continued)
Panel Luncheon
12:00 pm – 1:45 pm Seminars 3 and 4 Non-Microscopic
10:00 am –11:30 am
Sign-out with the Workshop 14
1:00 pm –2:00 pm Professor 11
10:00 am –12:00 pm Virtual Slide Seminar 7
1:30 pm –3:30 pm Microscopic Workshop 6
10:00 am –12:00 pm Microscopic Workshop 7
*2:00 pm – 3:30 pm State of the Art
Symposium Non-Microscopic
10:30 am –12:00 pm
Non-Microscopic Workshop 15
2:00 pm – 3:30 pm Workshop 11 Video Microscopy
10:30 am – 12:00 pm
2:00 pm – 4:00 pm Virtual Slide Seminar 6 Tutorial 10
Non-Microscopic *11:00 am – 12:00 pm JASC Hot Topics
3:00 pm – 4:00 pm Mini Workshop 4
*Scientific Sessions
Please Note: Pre-registration is recommended. If you register onsite, handouts will not be available until after the meeting.
Registration
The ASC Registration Package enables you to earn up to 40 CME/CMLE
and 28.5 SAM credits for attending Scientific Sessions and Poster and
Platform Presentations. Plus, it provides you free access to 3 continental
breakfasts, 6 refreshment breaks and 2 networking receptions.
Everyone attending the Annual Scientific Meeting is required to register prior to admission to
any session or the Exhibit Hall. Identification badges are provided and are required to enter all
sessions and the Exhibit Hall.
General Information
The Registration Desk is Saturday, November 11th
open as follows:
7:00 am – 8:00 am Continental Breakfast
Thursday, November 9rd 4:00 pm - 7:00 pm
10:00 am – 11:00 am Refreshment Break
Friday, November 10th 7:00 am - 5:30 pm
3:30 pm – 4:30 pm Refreshment Break
Saturday, November 11th 6:30 am - 5:30 pm
President’s Welcome
6:30 pm – 8:30 pm Reception
Sunday, November 12th 6:30 am - 5:30 pm
7:00 am – 1:00 pm Exhibit Hall Open Presenters are required to be at posters during
continental breakfast and refreshment breaks.
7:00 am – 8:00 am Continental Breakfast
Target Audience
This Meeting is designed for pathologists, cytopathologists, cytotechnologists,
students, and other members of the cytopathology community.
Educational Objectives
The American Society of Cytopathology’s 65th Annual Scientific Meeting will:
• Define the current practice of • Prepare cytotechnology students
cytopathology, and translate the latest and pathology trainees to meet the
techniques and guidelines into easily cytopathology needs of the future.
accessible take-home points. • Create a forum for sharing ideas
• Report the latest in cytology research and enabling advocacy on behalf of
during scientific plenaries, platform cytologists and their patients.
presentations, and poster sessions.
Access to the online evaluations, handouts, The American Society of Cytopathology designates
and credit claiming will be on the ASC Web this live educational activity for a maximum of 40
AMA PRA Category 1 Credits™. Physicians should
site: cytopathologymeeting.org. claim only the credit commensurate with the extent
of their participation in the activity.
The site is available DURING and for 30 days
AFTER the Annual Scientific Meeting and can Continuing Medical Laboratory Education (CMLE):
be accessed onsite using the terminals in The ASC designates this activity for a maximum of
40 Continuing Medical Laboratory Education (CMLE)
the Cyber Café, from any web browser at any
credit hours for non-physicians. The CMLE credit
time, or from the ASC Mobile App. You must hours meet the continuing education requirements
complete all session evaluations that you for the ASCP Board of Registry Certification
attended to receive credits. Maintenance Program. Participants should claim
only the credit commensurate with the extent of
Please note: You may evaluate and complete their participation in the activity.
Self-Assessment Modules (SAMs) and later American Board of Pathology Maintenance of
re-enter the site to print a certificate, or Certification (MOC): The 65th Annual Scientific
email yourself a certificate. No printers are Meeting will have up to 80 courses available to
available onsite. help fulfill the CME requirements mandated by
the American Board of Pathology Maintenance
ASC Members have the capability to track all of Certification (MOC) process.
ASC educational credits from year to year.
Visit the ASC Web site for more information. Earn up to 28.5 SAM Credits
Self-Assessment Modules (SAMs): The 65th Annual
Earn up to 40 CME and CMLE Credits Scientific Meeting will offer sessions (maximum of
28.5 credits) requiring completion of (SAM) to test
Credits by day: Friday 10 | Saturday 13.75 | knowledge. Video Microscopy Tutorials, Microscopic
Sunday 12.75 | Monday 3.5 and Non-Microscopic Workshops, Panel Luncheon
Seminars, Virtual Slide Seminars, and select
Continuing Medical Education (CME): The Scientific Sessions qualify for SAMs.
American Society of Cytopathology is accredited
by the Accreditation Council for Continuing The ASC will provide ONLINE session evaluations
Medical Education (ACCME) to provide continuing for all attendees to complete in order to receive
medical education for physicians. a certificate for CME/CMLE/SAM credits. This
activity is approved for continuing education credits
in the State of Florida and the State of California.
Schedule
Networking
This is a great chance for first-time attendees to meet
and mingle with the ASC Executive Board and long-time
members who can help them navigate their time and
experience at the Annual Scientific Meeting. It is also a great
opportunity to reach out to fellow first-timers in an effort to
at aEvents
turn unfamiliar faces into friends. Enjoy some beverages and
light snacks as we spin the wheel for some fun prizes!
Glance
ASC President's Welcome Reception with Exhibitors
Saturday, November 11th | 6:30 pm – 8:30 pm
Grand Ballroom
After a full day of Scientifc Sessions, stretch your legs at
the President’s Welcome Reception taking place in the ASC
Exhibit Hall. See the latest in industry equipment, products
and services while getting a bite to eat and drink among
friends and colleagues.
ASC Young
CYTOLOGY Investigator Grant
SHARK TANK
Saturday, November 11, 2017
5:30 pm – 6:30 pm
Eric Huang, MD, PhD Sinchita Roy-Chowdhuri, Vivian Weiss, MD, PhD
University of California, Davis MD, PhD Vanderbilt University
Sacramento, CA The University of Texas Medical Center
MD Anderson Cancer Center Nashville, TN
Proposal: Diagnostic Utility
Houston, TX
of Raman Spectroscopy Proposal: The Use of Next
in Differentiating Thyroid Proposal: Mutational Generation Sequencing to
Nodules and Identifying Profiling of Centrifuged Identify the Molecular and
Thyroid Cancers Supernatant Fluid from Immunologic Mechanisms
Fine Needle Aspiration of of Thyroid Cancer Invasion
Thyroid Nodules to Develop Improved FNA-
based Testing
The Cytology Shark Tank Aquarist (moderator) for the Be there to support
evening will be Dr. Liron Pantanowitz (University of
Pittsburgh), and the Sharks (judges) will be Dr. Douglas
and encourage our
Clark (University of New Mexico), Dr. Martha Pitman three finalists as they
(Massachusetts General Hospital and Harvard Medical dive into the ASC
School), Dr. Celeste Powers (Virginia Commonwealth Cytology Shark Tank!
University), and Dr. David Rimm (Yale University).
Special Events
7:00 pm – 9:30 pm
Scientific Sessions
5:30 pm – 6:30 pm Gathering for First-time Attendees
This is a great chance for first-time attendees
Grand Veranda to meet and mingle with the ASC Executive
Board and long-time members who can help
them navigate their time and experience at
the Annual Scientific Meeting. It is also a great
opportunity to reach out to fellow first-timers
in an effort to turn unfamiliar faces into friends.
Enjoy some beverages and light snacks as we
spin the wheel for some fun prizes!
ADDITIONAL COURSES
Attendees must pre-register in advance and receive a ticket,
before entrance to these sessions will be honored.
Meeting Program
Jeffrey F. Krane, MD, PhD 1.0
Ocotillo A Foyer
Meeting Program
3:00 pm – 4:30 pm Non-Microscopic Workshop 3
Soft Tissue Tumors that Mimic Carcinomas
Palm 2 AB CME/CMLE/Sam
in Fine Needle Aspiration: Pearls and Pitfalls
Xiaohua Qian, MD, PhD 1.5
Vickie Y. Jo, MD
Scientific Sessions
Meeting Program
11:00 am – 12:00 pm Platform Presentations 1-4 CME/CMLE
1.0
Sonoran Sky Ballroom
Moderators: Anne M. Mills, MD
Susan A. Alperstein, MS,
CT(ASCP)
Meeting Program
Gynecologic Cytology
Brock Martin, MD
Stanford University School of Medicine, Stanford, CA
ADDITIONAL COURSES
Attendees must pre-register in advance and receive a ticket,
before entrance to these sessions will be honored.
Meeting Program
1.75
Zhongren D. Zhou, MD, PhD 8. Quality Control: Evaluation of PD-L1
and Other Immunohistochemical
Tests for the Lung Non-small Cell Lung CME/CMLE
Cancer Cytologic Samples 1.75
Abha Goyal, MD 9. The Limited Cytology Specimen:
How to Enhance the Diagnostic Yield
and Diagnostic Specificity CME/CMLE
1.75
Melissa Klein, BS, CT(ASCP) 10. Management of FNA ROSA Services SAT
at Multi-centered Health System:
Strategies for Coordination, Coverage CME/CMLE
and Staff Justification 1.75
Gabriela M. Oprea-Ilies, MD 11. Combining Recent Medical Technology
Eric L. Flenaugh, MD Advances and Rapid On-site Evaluation
to Optimize Patient Centered Practice CME/CMLE
1.75
10:00 am – 12:00 pm Virtual Slide Seminar 2
Diagnostically Challenging Core Biopsy
Ocotillo B CME/CMLE/Sam
and Fine Needle Aspiration Cytology:
Israh Akhtar, MD How Much Can We Offer? 2.0
Varsha Manucha, MD
Meeting Program
Haijun (Steve) Zhou, MD, PhD 1.5
Meeting Program
Maximilian Diehn, MD, PhD Dr. Diehn’s laboratory focuses on two main
areas: 1) cancer stem cell biology and its
implications for therapy and 2) development
of genomics-based biomarkers for identifying
the presence of malignant cells (diagnostic),
predicting outcome (prognostic), and
predicting response to therapy (predictive).
Areas of study include cancers of the lung,
breast, and gastrointestinal system. They
are also interested in developing a deeper
molecular understanding of normal and
cancer stem cells, including identifying SUN
pathways and genes important for survival
and self-renewal. Additionally, they are
developing methods for overcoming
resistance mechanisms to radiotherapy and
chemotherapy in cancer stem cells.
ADDITIONAL COURSES
Attendees must pre-register in advance and receive a ticket, before entrance to these sessions
will be honored.
Meeting Program
Donna K. Russell, MEd, CT(ASCP)HT 2.0
Meeting Program
Renu K. Virk, MD Cytologist and Endoscopist to Enhance 1.5
Patricia Tiscornia-Wasserman, MD Diagnostic Accuracy
Tamas A. Gonda, MD
Scientific Sessions
Meeting Program
will be honored.
End of Program
Schedule is subject to change
JOIN US!
Washington DC
November 10 – 13, 2018
Omni Shoreham Hotel • Washington, DC
Annual Business Meeting & Awards Schedule
4/C
Schedule
Awards
at a Glance
November 12, 2017 | 5:30 pm – 6:30 pm
Sonoran Sky Ballroom
gray
Annual Business Meeting ASC Awards Presentation
black
VII. Induction of the New President
Presentation Award
d. Warren R. Lang, MD Resident
VIII. Announcement of 2017-2018 Physician Award
Committee Chair Appointments
3. Excellence in Education Award
IX. Announcement of the
4. President’s Award
Next Business Meeting
5. Cytotechnologist Award for
X. Adjournment Outstanding Achievement
6. Papanicolaou Award
Dr. Howell will present the Papanicolaou Address on Sunday, November 12th at 9:00 am, and
wil receive the Papinicolaou Medal during the ASC Business Meeting on Sunday, November 12th
at 5:30 pm.
Schedule
Washington University in St. Louis, where he is currently a Lecturer in
the Department of Psychological & Brain Sciences. Tim’s teaching and
research focus on positive psychology and college student
development. He is the recipient of the Dean’s Award for Teaching
Awards
Excellence at Washington University as well as the Outstanding
Research Award from the National Association for Orientation,
at a Glance
Transition, and Retention in Higher Education. His research and ideas
have been featured in a number of media outlets including Fast
Company, CNN, and the Associated Press.
Timothy J. Bono, PhD will receive the Guest Lecture Award and present the Guest Lecture during the
Scientific Session on Saturday, November 11th at 9:00 am.
Maximilian Diehn, MD, PhD will present the Leopold Koss Lecture and receive an award during the
Scientific Session on Sunday, November 12th at 11:00 am.
Kalyani Naik will receive her award during the Annual Business Meeting on Sunday, November 12th
at 5:30 pm.
Schedule
is in recognition of meritorious service or accomplishments in
the field of cytopathology education to include the education of
cytotechnologists, pathology residents and/or cytopathology fellows.
Awards
at a Glance
Brian T. Collins, MD
Dr. Brian T. Collins had an infectious enthusiasm for pathology and
promoted education and innovation in cytopathology. He was the
Chair of the Scientific Program Committee for the American Society of
Cytopathology and an ASC Executive Board member.
Dr. Collins was born in West Virginia and attended the University of
Missouri, Kansas City where he received a Bachelor of Arts as well as
his MD. He completed his pathology residency at Indiana University
and was Associate Professor and Section Head of Cytopathology
at Washington University in St. Louis. He was the cytopathology
fellowship program director at Barnes-Jewish Hospital and Medical
Director of the cytotechnology program at Saint Louis University.
Dr. Collins was a proponent of new practice paradigms including telepathology and used
evidenced-based research to advocate for ROSE FNA biopsy service. Within the ASC, as a
member of the Scientific Program Committee in 2015, he helped to bring the Virtual Slide
Seminars to the meeting, assisting the presenters in developing this mode of education. In
addition, he was a moderator of the Current Issues in Cytology Session at the 2016 Annual
Scientific Meeting on “Telecytopathology: Challenges and Opportunities,” again advocating
for the validation and use of these tools in daily practice.
He published 120 peer-reviewed journal articles, 75 abstracts and book chapters. As an educator,
he presented at national workshops, ASC annual meetings and teleconferences. Dr. Collins joined
the ASC as a resident member and consistently participated in ASC Annual Scientific Meetings.
Dr. Collins was always motivating to trainees. He would work with them individually to achieve
their goals and address any weak areas. He had an excellent knowledge of the profession,
superb diagnostic and teaching skills, and novel ideas. Dr. Collins has trained many excellent
cytopathologists who are actively practicing cytopathology in both academic and private settings.
His enthusiasm for teaching dated back to the years following his fellowship in cytopathology,
On December 23, 2016, Dr. Brian Collins passed away unexpectedly. Besides his profession,
Dr. Collins was devoted to his family. Dr. Collins was a wonderful gift to the cytopathology
community.
The 2017 Excellence in Education Award will be presented to Virginia Collins, wife of the late
Brian T. Collins, MD during the ASC Business Meeting on Sunday, November 12th at 5:30 pm.
Christina S. Kong, MD
Dr. Christina Kong is a pathologist who attended medical school at UC San
Francisco with plans to become a pediatrician. After a rotation with
screaming kids and screaming parents, she went on a quest to find a different
specialty. The vibrant colors of a Giemsa stained slide caught her imagination
during an OB-GYN rotation, but she had a hard time letting go of direct
patient care. Before discovering she could see patients as a cytopathologist,
she completed an internship in Internal Medicine in case she changed her
mind about pathology. She envisioned a career as a community-based
pathologist and pursued broad-based training with residency in Anatomic &
Clinical Pathology at UCSF, Surgical Pathology Fellowship at Stanford and
Cytopathology Fellowship at UCSF. Of course, life never quite turns out as
expected and after a short stint in community practice, Dr. Kong joined the
faculty at Stanford where she is currently Director of the Cytopathology
Service and Fellowship, and Medical Director of Anatomic Pathology & Clinical Lab Services at Stanford.
For fun and relaxation, she throws pottery, bakes cookies, and goes hiking.
Kristen A. Atkins, MD
Dr. Kristen A. Atkins was first attracted to pathology because she admired
many of the pathologists who were superb teachers. After AP residency at
Stanford, she did her cytology fellowship at Virginia Commonwealth
University where again she was struck by the very gifted teachers in both
the physician and cytotechnologist realms and loved the numerous
teaching opportunities (from trainees to patients to peers) that this
discipline offered. Since her training, she has received numerous teaching
awards from medical students and residents and received the University of
Virginia Master Educator award in 2015 and the Alumni Distinguished
Academic Achievement award from the University of Vermont in 2016.
Her primary education love is the one-on-one teaching that comes with
working with trainees. In the words of one of her recent graduating
fellows, “She is a natural teacher who by her poetic words and descriptions makes cells come alive
before your eyes. With her, learning is an easy and memorable experience. She goes to great lengths
to help you understand new concepts even if it means ordering a bag of pulled taffy (for someone
who has never seen or tasted it) to explain the appearance of mucin on a slide. With her guidance,
she sets you up for success in cytology, your career and, most importantly, life.”
Dr. Atkins’ presented her first workshop at the ASC in 2001 and since then has presented over 50
workshops as an invited speaker in cytology at national and international meetings. After several
years on the Scientific Program Committee, she became the chair, and stepped in as Co-Chair when
the need arose.
Dr. Kong and Dr. Atkins will receive their awards during the Annual Business Meeting on Sunday,
November 12th at 5:30 pm.
Schedule
The ASC Foundation awards $2,000 each to qualified individuals,
who are ASC members, to attend the ASC Annual Scientific
Awards
Meeting. This scholarship, based on need and merit, defrays
registration, travel and hotel costs.
at a Glance
2016 Cytotechnologist 2017 Fellow and
Recipients Resident Recipients
The ASC Foundation congratulates The ASC Foundation would like to
the following recipients of the 2016 congratulate the following receipients
Cytotechnologists Travel Scholarships of the 2017 Fellows and Residents
Travel Scholarships
For attendance at the 65th Annual Scientific
Meeting in Phoenix, Arizona For attendance to the 65th Annual Scientific
Meeting in Phoenix
Monica Dorda, BS, CT(ASCP)
University of Wisconsin Deepu Alex, MD, PhD
Madison, WI Memorial Sloan-Kettering Cancer Center
New York, NY
Kathryn Kiely, CT(ASCP)CM
Strong Memorial Hospital Emilio Madrigal, DO
Rochester, NY Emory University
Atlanta, GA
Maria Ella Lim, CT(ASCP)
New York Presbyterian Medical Center Alexandra R. Nichols, MD
New York, NY University of Virginia
Charlottesville, VA
Emily McMeekin, BS, CT(ASCP)CM
Cleveland Clinic Foundation Vanda F. Torous, MD
Cleveland, OH Beth Israel Deaconess Medical Center
Harvard Medical School
Kelsey Snyder, BS, CT(ASCP) Boston, MA
Roswell Park Cancer Institute
Buffalo, NY Amy G. Zhou, MD
The Johns Hopkins Hospital
Baltimore, MD
Congratulations!
to all ASC Foundation Scholarships Recipients!
Poster Presentations
Saturday, November 11th
Presenters are required to be at posters during All posters must be dismantled by 7:00 pm or they
continental breakfast and refreshment breaks. may be discarded.
ANAL
1. The Adequacy of Patient Collection of Anal Cytology Specimens
Mariam Mir, MD, Joel Thibodeaux, MD, Joselin Anandam, MD, Arti Barnes, MD, Andrew Bieterman, MS,
Andrew Quinn, MD
University of Texas Southwestern Medical Center, Dallas, TX
3. Correlation of Anal Papanicolaou Smears with Follow-up Histology and Human Papillomavirus
Genotyping from an Academic Medical Center
Amanda M. Hopp, MD1, Mamta Pant, MD1, Sally Sniedze, CT(ASCP)2, Razvan Lapadat, MD1,
Lauren Parsons, MD1, Bryan Hunt, MD1, Tamara Giorgadze, MD1
Medical College of Wisconsin, Milwaukee, WI1 Wisconsin Diagnostic Laboratories, Milwaukee, WI2
4. Prospective Rescreening of Anal Pap Smears Associated with Increased Risk for
Developing Anal Cancer
Rochelle Nagales Nagamos, MD, MBA, Melissa Stemmer, MBA, CT, Cindy Steele, SCT(ASCP),
Kamal Khurana, MD
SUNY Upstate Medical University, Syracuse, NY
BREAST
5. Diagnostic Value of Intraoperative Rapid Cytokeratin Immunostain in the Cytological Evaluation
of Sentinel Lymph Nodes in Patients with Invasive Lobular Carcinoma
Marilin Rosa, MD, Emmanuel Agosto-Arroyo, MD, Ardeshir Hakam, MD, MBA, Barbara Centeno, MD,
Nancy Mela, CT(ASCP), Laila Khazai, MD
Moffitt Cancer Center, Tampa, FL
EDUCaTION
8. A Model Residency Curriculum in Cytopathology
Erik Washburn, MD1, Susan Fluck, CT2, Catherine Abendroth, MD2
Penn State Hershey Medical Center, Hummelstown, PA1 Penn State Health Hershey Medical Center, Hershey, PA2
10. Providing Feedback to Trainees on Cytology Diagnostic Skills Using CoPath Correlation Reports
Sara Monaco, MD, Jackie Cuda, SCT(ASCP), Marie DeFrances, MD, PhD, Liron Pantanowitz, MD
University of Pittsburgh Medical Center, Pittsburgh, PA
Education (continued)
11. Cytotechnology Student Education Enhancement through the Implementation of
PathXLTM Tutor Software as a Solution for Digital Cytomorphology Training
Karyn Varley, MS, SCT(ASCP)1, Beth Mosley, MS, SCT(ASCP)2, Matthew Hanna, MD2,
Poster Presentations
Liron Pantanowitz, MD2, Bradley Clifford, MBA2
Magee-Womens Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA1 University of Pittsburgh Medical Center,
Pittsburgh, PA2
12. Utilizing Microsoft Publisher® as a Problem Based Learning Tool for Cytotechnology (CT) Students
Sandra Dolar, BA, SCT(ASCP), Jennifer Brainard, MD, Dawn Underwood, MS, CT(ASCP)
Cleveland Clinic, Cleveland, OH
14. Beyond the Microscope: Emotional Intelligence Program Adds Value to Cytotechnology Training
Amanda Bruening, MS, CT(ASCP), Sandra Dolar, BA, SCT(ASCP), Erica Kaplan, MS, CT(ASCP), MB(ASCP),
Jennifer Brainard, MD
Cleveland Clinic Foundation, Cleveland, OH
FLUIDS
16. Our 16-year Institutional Experience on Malignant Effusion Cytology at the Cleveland Clinic
Maria Luisa Policarpio-Nicolas, MD, Josephine Kam Tai Dermawan, MD, PhD
Cleveland Clinic, Cleveland, OH
GI
19. Biliary Cytology in Assessment of Bile Duct Strictures – An Institutional Experience
Yue Hua Ho, BS (Biomedical), Sangeeta Mantoo, FRCPath (UK)
Singapore General Hospital, Bukit Merah, Singapore
20. Utility of Next-Generation Sequencing compared to FISH for Detection of High-Risk Lesions in
Bile Duct Brushings in Patients with Primary Sclerosing Cholangitis
Matthew Rosenbaum, MD, Martha Pitman, MD, Raza Hoda, MD, Jonathan England, MD,
Anthony Iafrate, MD, PhD, Long Le, MD, PhD, Ronald Arpin, MS, SCT(ASCP)MB
Massachusetts General Hospital, Boston, MA
GI (continued)
21. Immunohistochemical Detection of VHL Expression is More Sensitive than Detection of
Albumin mRNA in the Diagnosis of Intrahepatic Cholangiocarcinomas on Fine Needle Aspiration
and Small Tissue Biopsy Specimens
Fan Lin, MD, PhD, Haiyan Liu, MD
Geisinger Medical Center, Danville, PA
24. A Comparison of Routine Cytology and UroVysion for the Detection of Pancreaticobiliary
Malignancies as a Quality Assurance Metric
Shira Ronen, MD, Tamara Giorgadze, MD, Jess Peterson, MD, Bryan Hunt, MD
Medical College of Wisconsin, Milwaukee, WI
25. Explore the Best Cut-off Value of Elastography Scores on EUS-FNA: The Experience of
109 Cases from a Single Academic Center
Suvra Roy, MD, Suhair Al Salihi, MD, Erik Rahimi, MD, Nirav Thosani, MD, MHA,
Jaiyeola Thomas-Ogunniyi, MBBS, FRCPath(UK), Songlin Zhang, MD
University of Texas Health Science Center, Houston, TX
GU
27. Inter-observer Agreement for Diagnostic Criteria of the Paris System for
Reporting Urine Cytology
Jia Qin, MD, PhD, Ronald Arpin, MS, SCT(ASCP)MB, Heather Grant, BS, SCT(ASCP) MBCM, Melissa Ring,
SCT(ASCP) MBCM, Athena Chen, MD, Mingjuan Zhang, MD, Rosemary Tambouret, MD, Ivan Chebib, MD
Massachusetts General Hospital, Boston, MA
28. Impact of the Paris System for Reporting Urinary Cytology on Cytotechnologist
Screening Diagnosis
J. Judd Fite, MD, MBA1, Derek Allison, MD1, Christopher VandenBussche, MD, PhD2
The Johns Hopkins University School of Medicine, Baltimore, MD1 The Johns Hopkins Hospital, Baltimore, MD2
29. Transitioning from the Johns Hopkins Template to the Paris System for
Reporting Urinary Cytology
Derek Allison, MD1, Dorothy Rosenthal, MD, FIAC1, Christopher VandenBussche, MD, PhD2
The Johns Hopkins University School of Medicine, Baltimore, MD1 The Johns Hopkins Hospital, Baltimore, MD2
GU (continued)
30. The Paris System for Reporting Urinary Cytology is Helpful to Reduce Atypical Diagnoses:
An Institution Experience
Juan Xing, MD1, Jacqueline Cuda, BS, SCT(ASCP)2, Liron Pantanowitz, MD2, Sara Monaco, MD2
Poster Presentations
Pathology Specialists of University of Pittsburgh Medical Center, Pittsburgh, PA1 University of Pittsburgh Medical Center,
Pittsburgh, PA2
31. Application of The Paris System for Reporting Urinary Cytology: What Should be the
Nuclear to Cytoplasmic Ratio to Diagnose High Grade Urothelial Carcinoma
Sanjana Mehrotra, MD
University of Colorado, Aurora, CO
33. Utility of The Paris System for Reporting Urinary Cytology in Upper Urinary Tract Specimens
Sara Monaco, MD1, Liron Pantanowitz, MD1, Juan Xing, MD2
University of Pittsburgh Medical Center, Pittsburgh, PA1 Pathology Specialists of University of Pittsburgh Medical Center,
Pittsburgh, PA2
34. Multilayer Perceptron Neural Network Analysis for the Diagnosis of High Grade Urothelial Carcinoma
Daniel Diaz, MD, Msc, Amir Momeni-Boroujeni, MD, Jonathan Somma, MD
SUNY Downstate Medical Center, Brooklyn, NY
36. Cell Block Preparations in Urinary Tract Cytology: A Golden Opportunity or a Nonseller?
Stefan Pambuccian, MD, Schuharazad Abro, MD, Guliz Barkan, MD
Loyola University Medical Center, Maywood, IL
37. CellDetect Histochemical Stain for the Monitoring of Urothelial Carcinoma in Clinical Setting
Alexander Shtabsky, MD1, Jörg Hennenlotter, Grad Biol2, Valentina Gerber, CT2, Yael Glickman, PhD3,
Noa Davis, PhD3, Tim Neumann2, Arnulf Stenzl, MD2, Tilman Todenhöfer, MD2
Tel Aviv Sourasky Medical Center, Tel Aviv, Israel1 University Hospital, Tübingen, Tuebingen, Germany2 Micromedic
Technologies Ltd., Tel Aviv, Israel3
38. Diagnostic Value and Accuracy of Touch Imprint Cytology in Kidney Tumor Biopsies;
A Big Institution Experience
Osamah (Sam) Albadri, MBChB, Yajue Huang, MD, PhD, Michael Henry, MD, Pingchuan Zhang, MD
Mayo Clinic, Rochester, MN
39. Optimizing the Use of a Voided Urine Cytology Specimen as Control Material for Anti – BK Virus
Immunohistochemical Staining
Sarah Kassaby, MD, Johanna Preiszner, PhD, George Youngberg, MD
East Tennessee State University, Johnson City, TN
40. Diagnostic Accuracy and Efficacy of Renal Pelvic Washing: Clinical and Pathologic Correlation
Nail Alouch, MD, Yun Gong, MD, Ming Guo, MD
University of Texas MD Anderson Cancer Center, Houston, TX
GU (continued)
41. Innovative Urinary Marker for Routine Use in the Identification of Bladder Cancer
Jacob Bejar, MD1, Marina Zlotnik, MSc1, Sarel Halachmi, MD1, Kohava Biton, RN1, Noa Davis, PhD2,
Yael Glickman, PhD2, Ofer Nativ, MD1
Bnai Zion Medical Center, Haifa, Israel1 Micromedic Technologies, Tel Aviv, Israel2
42. The International Society of Urological Pathology (ISUP) Grading System Shows High
Interobserver Reliability in Fine Needle Aspiration (FNA) Biopsies of Renal Cell Carcinoma
Stefan Pambuccian, MD, Guliz Barkan, MD, Swati Mehrotra, MD, Razan Massarani-Wafai, MD,
Grazina Chatt, CT(ASCP), Eva Wojcik, MD
Loyola University Medical Center, Maywood, IL
43. A Retrospective 24-year Single Institution Study of Renal Oncocytic Neoplasms Diagnosed by
Fine Needle Aspiration
Adam Miller, MD, Euna Choi, MD, Harvey Cramer, MD, Robert Emerson, MD, Howard Wu, MD,
Shaoxiong Chen, MD, Xiaoyan Wang, MD
Indiana University School of Medicine, Indianapolis, IN
44. Histopathologic and Clinical Follow-up of Fine Needle Aspiration Biopsies of Renal Masses:
An 11-year Retrospective Analysis
Carmen Perrino, MD, Harvey Cramer, MD, Muhammad Idrees, MD, Howard Wu, MD
Indiana University, Indianapolis, IN
GYN
47. Utility of Ovarian Scrape Preparations for the Intraoperative Diagnosis of
Ovarian Epithelial Lesions
Kelly Hanley, DO1, Charles Sturgis, MD2, Jennifer Brainard, MD2, Kathryn Dyhdalo, MD2, Sarah Share, MD2
Cleveland Clinic Foundation, Cleveland, OH1 Cleveland Clinic, Cleveland Heights, OH2
48. A Limited Immunostain Panel Including Napsin A for the Diagnosis of Ovarian Clear Cell
Carcinoma - Maximizing the Utility of Cytology Specimens
Avani Pendse, MBBS, PhD1, Renee Betancourt, MD2, Anna Bauer, PhD2, Leslie Dodd, MD2
University of North Carolina Hospital, Chapel Hill, NC1 University of North Carolina, Chapel Hill, NC2
49. Correlation of Pap Test Diagnoses with Histologic Diagnoses of Endometrial Carcinoma:
A Five-year Retrospective Study
Mariam Mir, MD, Kyle Molberg, MD, Stacy Hinson, MD, Joel Thibodeaux, MD, Elena Lucas, MD
University of Texas Southwestern Medical Center, Dallas, TX
GYN (continued)
51. Significance of Endocervical Curettage after Normal Colposcopy in the
Detection of Cervical Dysplasia
Ghassan Tranesh, MD, FCAP, Vighnesh Walavalkar, MD, Farnaz Hasteh, MD
Poster Presentations
University of California San Diego, San Diego, CA
52. Atypical Glandular Cells on Papanicolaou Test: The Fate and Follow-up of 51 Cases
Marcos Lepe, MD1, Claire Eklund, CT(ASCP)2, M. Ruhul Quddus, MD, M Phil (Path)3, Cherie Paquette, MD3
Brown University/Rhode Island Hospital, Providence, RI1 Woman and Infants Hospital, Providence, RI2 Women and Infants
Hospital/Brown University, Providence, RI3
53. Glandular Cell Abnormalities on Pap Tests: Comparing Detections Rates and Cytology-Histology
Correlations of Conventional and Liquid Based (BD SurePath) Methods
Karen Cormier, BSc, CT (ASCP), Brandy Callahan, CT(ASCP), Gabor Fischer, MD, PhD
Diagnostic Services Manitoba, Winnipeg, Canada
54. Endocervical Glandular Involvement is Associated with Higher Rates of HSIL and ASC-H
Diagnoses on Preceding Pap Test
Robby Jones, MD, Fransiska Dale, Christopher VandenBussche, MD, PhD
The Johns Hopkins University School of Medicine, Baltimore, MD
56. Comparing Outcomes in High-risk Human Papillomavirus (hrHPV) Positive Women with
Negative Versus Atypical Squamous Cells of Undetermined Significance (ASC-US) Cytology
Stratified by HPV Typing
Josephine Aguilar-Jakthong, MD, Opal Reddy, MD, Jianyu Rao, MD, Po Chu Fung, MBA, SCT(ASCP)
University of California, Los Angeles, CA
58. Infections with Multiple High-risk Human Papillomavirus (HPV) Types are Associated with
More High-grade Squamous Intraepithelial Lesions (HSIL) on Follow-up Cervical Biopsy
Remegio Maglantay, MD, Brenda Sweeney, MS, SCT, CLA(ASCP)MBCM, Ivan Chebib, MD, David Wilbur, MD
Massachusetts General Hospital, Boston, MA
59. Tandem Reflex Human Papilloma Virus Testing: A Strategy in a High Volume Practice
Siavash Samimi, MD1, Donna Armylagos, CT(ASCP)2, Eric Luna, CT(ASCP)2, Nicola Dundas, MD1,
Dina Mody, MD1, Michael Thrall, MD1
Houston Methodist Hospital, Houston, TX,1 BioReference Laboratories, Houston, TX2
60. HPV Negative Rates with Roche cobas Platform in Patients with CINII+ and Invasive
Squamous Cell Carcinomas.
Abel Gonzalez, MD, Akosua Ametorgoh, MS, CT(ASCP), PTA, MT, Patricia Tiscornia-Wasserman, MD
Columbia University Medical Center, New York, NY
GYN (continued)
61. The Comparison of Genotyping and Histologic Outcomes Between ThinPrep and
SurePath Preparations in Women with Negative Cytology and Positive HPV Tests:
A Single Institution Experience
Youssef Youssef, MD, Rulong Shen, MD, Dena Tonkovich, BS, CT(ASCP), Zaibo Li, MD, PhD, MBA
The Ohio State University, Columbus, OH
62. A Comparison of the Roche cobas HPV Test Using Three Different Preparation Methods
for the Detection of High-risk Human Papillomavirus Genotypes on SurePath Samples
Seema Khutti, MD, Shweta Gera, MD, DY Goldstein, MD, Samer Khader, MD, FCAP, FIAC,
Stacia Semple, MD, Mark Suhrland, MD, Amy S. Fox, MD, MS
Montefiore Medical Center, Bronx, NY
63. Potential Efficacy of Primary hrHPV Screening Utilizing the SurePath Pap/Aptima
Assay HPV Platform
Matthew Ohtani, BS1, Andi Cuniberti, CT(ASCP)2, Pamela Tauchi-Nishi, MD2
Hawaii Pathologists Laboratory, Honolulu, HI1 University of Hawaii/Queens Medical Center, Honolulu, HI2
65. HPV RNA In Situ Hybridization Can Inform Cervical Cytology-Histology Correlation
Joseph Coppock, MD, PhD, Brian Willis, MD, Mark Stoler, MD, Anne Mills, MD
University of Virginia, Charlottesville, NC
69. Comparison of Digital Imaging and Light Microscopy for Liquid-based Gynecologic
Cytology Diagnosis
Rosemary Tambouret, MD1, Amy Ly, MD1, Heather Grant, BS, SCT(ASCP) MBCM1, Mary Rego, BA, SCT(ASCP)
MBCM1, Brenda Sweeney, MS, SCT, CLA(ASCP)MBCM1, Omonigho Aisagbonhi, MD, PhD1, Louis Vaickus, MD,
PhD2, David Wilbur, MD1
Massachusetts General Hospital, Boston, MA1 Dartmouth-Hitchcock, Lebanon, NH2
GYN (continued)
70. Follow Up and Outcomes for Patients with Negative Papanicolaou (Pap) Test and Positive
High-risk Human Papillomavirus (hrHPV+) Co-testing
Elza Matrova, MD, Kristen Wilkins, MBA, SCT(ASCP), Robert Cabay, MD, DDS, Odile David, MD
Poster Presentations
University of Illinois, Chicago, IL
71. Prior Knowledge of High-risk HPV Status Results in Higher Rate of ASCUS Interpretation
and Potential Increase in Pathologists` Workload
Shannon O`Brien, MD, Melinda Lewis, MD, Kimberly Heiman, BS, CT(ASCP), Krisztina Hanley, MD
Emory University School of Medicine, Atlanta, GA
73. Reducing the Number of Unsatisfactory ThinPrep® Pap Tests Through Novel Blending Technique
Stephanie Hamilton, EdD, SCT, MB(ASCP), Nuria Perez-Reyes, MD
CellNetix Pathology and Laboratories, Seattle, WA
74. Comparing Rapid Prescreening, BD FocalPoint Profiler and the Combination of the
Two as a Quality Assurance Method in Gynecologic Cytology
Gabor Fischer, MD, PhD, Karen Cormier, BSc, CT(ASCP)
Diagnostic Services Manitoba, Winnipeg, Canada
76. Characteristic Findings of Cervical Pap Tests from Transgender Patients on Androgen Therapy:
Challenges in Detecting Dysplasia
Brian Adkins, MD, Vivian Weiss, MD, PhD, Annie Jack, MBA, Stephen Schultenover, MD, Mohamed
Desouki, MD, PhD, Alice Coogan, MD
Vanderbilt University Medical Center, Nashville, TN
81. The Diagnosis of Warthin Tumor on Fine Needle Aspiration: Potential Pitfalls
Daniel Miller, MD, PhD1, Sintawat Wangsiricharoen, MD2, Christopher VandenBussche, MD, PhD1
The Johns Hopkins Hospital, Baltimore, MD1 Chiang Mai University, Chiang Mai, Thailand2
82. Cytomorphologic Features Associated with Risk of Malignancy in Basaloid and Oncocytic
Salivary Gland Neoplasms
Deepika Savant, MD, Cao Jin, MD, Karen Chau, CT(ASCP), Lisa Rosen, ScM, Tamla Hagan, CT(ASCP),
MCP, Maruf Chowdhury, MBA, SCT(ASCP)CMIAC, Joshua Koppenhafer, MPH, SCT(ASCP), Mercedes Kercy,
CT(ASCP), Rubina Cocker, MD, FCAP, Cecilia Gimenez, MD, Alice Laser, MD, Kasturi Das, MD
Hofstra Northwell School of Medicine, Lake Success, NY
85. Cytopathologic Features of INI-1 Deficient Sinonasal Carcinoma: Two Institutions’ Experience
Felicia Allard, MD1, Diana Bell, MD2, Edward Stelow, MD3
University of Oklahoma, Oklahoma City, OK1 MD Anderson Cancer Center, Houston, TX2 University of Virginia, Charlottesville, VA3
LUNGS
87. The Clinical Utility of Bronchoalveolar Lavage in Pediatric Population: A Clinical and
Cytopathological Perspective
Abhishek Gami, BS1, Zahra Maleki, MD2
The Johns Hopkins University, Baltimore, MD1 The Johns Hopkins Hospital, Baltimore, MD2
Lungs (continued)
89. Reassessing the Clinical Usefulness of Preliminary/STAT Evaluation for Pneumocystis
Jirovecii Oneumonia on DiffQuikR Smears
Ronald Encarnacion, BS, Chen-Yen Chang, CT(ASCP), Adele Kraft, MD
Poster Presentations
Virginia Commonwealth University Health, Richmond, VA
90. Primary Salivary Gland Tumors of the Tracheobronchial Tree Diagnosed by Transbronchial Fine
Needle Aspiration: Clinical and Cytomorphologic Features with Histopathologic Correlation
Erika Doxtader, MD1, He Wang, MD, PhD2, Yaxia Zhang, MD, PhD1
Cleveland Clinic, Cleveland, OH1 Temple University, Philadelphia, PA2
92. Correlation of Rapid Onsite Evaluation with Cytology and Molecular Outcomes on
Small Thoracic Specimens
Maria Ella Lim, CT(ASCP), Adam Pacecca, MS, Renu Virk, MD, Teresa Wood, CT(ASCP), MPH,
Patricia Tiscornia-Wasserman, MD
New York Presbyterian Hospital/Columbia University Medical Center, New York, NY
93. Impact of Size and Histologic Type of Pulmonary Carcinoma on Diagnostic Yield of
Endobronchial Ultrasound-directed Fine Needle Aspiration
Ahmad Ibrahim, MD, Ahmad Al-Rajjal, MD, Jacob Edens, MD, Malak Kanbour, MPH, Susanna Szpunar,
PhD, Fred Erndt, BA, Paul Mazzara, MD
St. John Hospital and Medical Center, Detroit, MI
94. Lack of Cost-effectiveness of EGFR, Ros-1, PD-L1 and ALK-Fish Testing in Lung Carcinoma
on FNA and Pleural Fluid Cell Blocks in the Veteran Patient
Linda Green, MD
Veterans Affairs Medical Center, Bellaire, TX
95. Minimum Lung Tumor Cell Threshold in Fine Needle Aspiration Cell Blocks Required for
Therapeutic Marker Studies
Daniel Coldren, MD, Keith Sweeney, MD, Maoxin Wu, MD, PhD
Stony Brook University Hospital, Stony Brook, NY
Lungs (continued)
99. PD-L1 Assessment in Thoracic Cytology Samples
Andrew Lerner, MD, Lonny Yarmus, DO, FCCP, Rajni Sharma, PhD, Peter Illei, MD
The Johns Hopkins Medical Institution, Baltimore, MD
100. PD-L1 Immunohistochemical Testing for Lung Cancer: Cytology and Surgical Pathology
Specimens Demonstrate Similar Overall Expression Patterns
Vanda Torous, MD, Deepa Rangachari, MD, Daniel Costa, MD, PhD, Paul VanderLaan, MD, PhD
Beth Israel Deaconess Medical Center, Boston, MA
105. Reliable Detection of EGFR Mutation by Allele-Specific PCR and ALK Gene Rearrangement by
FISH in Non-Small Cell Lung Carcinoma Using Liquid-based Cytology Sample: Hing Concordance
with Next-Generation Sequening Performed on Cell Block Material
Longmei Zhao, MD, PhD1, Erika Doxtader, MD1, Xiaoqi Lin, MD, PhD2, Yaxia Zhang, MD PhD1
Cleveland Clinic Foundation, Cleveland, OH,1 Northwestern University, Chicago, IL2
107. p40 is Superior to p63 and CK5/6 for Differentiating Lung Squamous Cell Carcinoma
from Adenocarcinoma in Cytological Specimens
Santiago Delgado, MD, Guoping Cai, MD
Yale University School of Medicine, New Haven, CT
LYMPH NODE
108. Evaluation of ThinPrep Cytology of Axillary Lymph Node FNA: An Institutional Experience
Yelena Fudym, DO, Rana Naous, MD, Kamal Khurana, MD
Poster Presentations
Upstate Medical University, Syracuse, NY
PANCREAS/LIVER
112. Fine Needle Aspiration of the Liver: A Ten-year Single Institution Retrospective Review
Kelsey McHugh, MD, Jordan Reynolds, MD
Cleveland Clinic Foundation, Cleveland, OH
113. Influence of Rapid On-site Evaluation on Adequacy of Needle Core Biopsies Done for
Diagnosis of Mass Lesions of the Liver
Saloni Walia, MD, Manju Aron, MD, Eugenia Hu, SCT, Shefali Chopra, MD
Keck School of Medicine, University of Southern California, Los Angeles, CA
114. Role of Fine Needle Aspiration in Post Liver Transplant Patients; A Clinical/Cytological Review
Prih Rohra, MD, Diana Lin, MD, Paolo Gattuso, MD
Rush University Medical Center, Chicago, IL
116. Clinical Features, Onsite Evaluation and Follow-up Results in Patients with Suspicious for
Adenocarcinoma on EUS-guided FNA of Pancreas
Youssef Youssef, MD, Rulong Shen, MD, Dena Tonkovich, BS, CT(ASCP), Zaibo Li, MD, PhD, MBA
The Ohio State University, Columbus, OH
PANCREAS/LIVER (continued)
118. Cytologic Features of Pancreatic Adenosquamous Carcinoma: A Single Institution
Retrospective Review
Daniel Abbott, MD, Bryan Hunt, MD, Razvan Lapadat, MD, Tamara Giorgadze, MD
Medical College of Wisconsin, Milwaukee, WI
123. In Era of Novel EUS Needles, the Differential Diagnosis of Clear Cell Tumors of
the Pancreas Should Include Serous Cystadenoma
Nathan Shelman, MD, Mary Sidawy, MD, Jay Zeck, MD
MedStar Georgetown University Hospital, Washington, DC
QA
124. Validation of Telecytology for Adequacy Assessment and Preliminary Diagnosis
using Live Streaming of Images of Diff Quik-stained Smears
Venetia Sarode, MD, Valerie Pena, CT(ASCP), Dana Wanzer, CT(ASCP), Susan Sanko, MBA, CT(ASCP)IAC,
Shirley Yan, MD
University of Texas Southwestern Medical Center, Dallas, TX
125. International Telecytology Feasibility Using Digitally Scanned Cell Block Slides
Andres Mosquera-Zamudio, MD1, Matthew Hanna, MD2, Sara Monaco, MD2, Juan Xing, MD2,
Thomas Harper, BS2, Chengquan Zhao, MD2, Liron Pantanowitz, MD2
Hospital de San José, Bogota, Colombia1 University of Pittsburgh Medical Center, Pittsburgh, PA2
QA (continued)
127. The Delivery of a Non-gynaecological Cytopathology External Quality Assurance Program
in Virtual Format (eQAP) – Can Whole Slide Images Provide Similar Diagnostic
Accuracy When Compared to Glass Slides in an EQA Setting?
Poster Presentations
Jennifer Ross, B App Science CT(ASC) CT(IAC)1, Janelle Greaves, ADCLT, CT(ASC)1, Simone Louise Van Es,
MBBS, FRCPA, PhD, Grad Dip Med, CertFPA2, Peter Earls, MBBS3, Boaz Shulruf, PhD2
RCPA Quality Assurance Programs Pty Ltd, Sydney, Australia1 University of New South Wales, Sydney,
Australia2 St. Vincents Hospital, Darlinghurst, Australia3
133. Cytotechnologist (CT) Role in Supporting Nephrology Patient Care through Full
Immunofluorescence (IF) Panel Screening
Amy Wendel Spiczka, MS, SCT, MB, HTL, Kristen Bifalco, CT(ASCP)CM, Longwen Chen, MD, PhD,
Matthew Zarka, MD, Maxwell Smith, MD
Mayo Clinic Arizona, Scottsdale, AZ
135. Diagnostic Value of Cytopathology and Flow Cytometry Analysis of Vitreous Humor
Colby Cantu, MD, Rajesh Dash, MD
Duke University Health System, Durham, NC
QA (continued)
136. Impact of Education on Institutional and Faculty ASC-US Rates
Emily McMeekin, BS, CT(ASCP)CM1, Jennifer Brainard, MD1, Amanda Bruening, MS, CT(ASCP)1,
Dawn Underwood, MS, CT(ASCP)1, Deborah Chute, MD2
Cleveland Clinic, Cleveland, OH1 Cleveland Clinic Foundation, Cleveland, OH2
140. Should Cytology Workload Limits Be Adjusted When Screening Digital Cytology Slides?
Matthew Hanna, MD, Jacqueline Cuda, BS, SCT(ASCP), Sara Monaco, MD, Liron Pantanowitz, MD
University of Pittsburgh Medical Center, Pittsburgh, PA
SPECIAL
141. Modified Plasma-thrombin Method of Cell Block Preparation for Fine-needle Aspiration Biopsies
in Resource-limited Settings
Omonigho Aisagbonhi, MD, PhD1, Abraham Birungi, BBLT2, Paddy Behayo, Bachelor of Science
Laboratory Technology2, Rosemary Tambouret, MD1
Massachusetts General Hospital, Boston, MA1 Mbarara University of Science and Technology, Mbarara, Uganda2
145. A Special Protocol for Cytology Level Sections Maximizes Use of Cell Block Material
Tara Saunders, MD, Sarah Calkins, MD
University of California San Francisco, San Francisco, CA
special (continued)
146. Core Needle Biopsy or Fine Needle-Aspiration: A Quality Improvement Study
Tamar Brandler, MD, MS1, Dana Warfield, MPA, CPHQ2, Margaret Cho, MD2, Akhilesh Sista, MD2,
Aylin Simsir, MD2
Poster Presentations
New York University Langone Medical Center, New York, NY1 New York University Medical Center, New York, NY2
153. Cytology Smears for DNA Extraction: Practical Approach to Choosing the Best Slide
Neha Gupta, MBBS, Ryan Brenkert, MS, SCT(ASCP), MB, Joong Lee, MD, Melissa Klein, BS, CT(ASCP),
Silvia Spitzer, PhD, Karen Chau, CT(ASCP), Kasturi Das, MD
Northwell Health, Lake Success, NY
THYROID CYTOLOGY
155. A Comparison Study of Thyroid Fine Needle Aspiration Performance With and Without
Rapid On-site Sample Adequacy Assessment
Sarmad Jassim, MD, Laura Royer, CT(ASCP), Santhi Ganesan, MD
MetroHealth Medical Center, Cleveland, OH
156. A Comparative Study of the Adequacy Rates in Thyroid Ultrasound-guided Fine Needle
Aspiration Using Rapid On-site Evaluation, with and without Telepathology Usage
Iris Juan, BSc, CT(ASCP), Erin Smith, CT(ASCP)
University of California San Francisco Medical Center, San Francisco, CA
157. Comparison of 95% Alcohol Immersion Fixation Versus Spray Fixation (PapFix) for Thyroid Fine
Needle Aspiration Regarding Overall Cellularity Cell Morphology and Amount of Colloid
Amro Almradi, MD, Osama Alassi, MD
Beaumont Health System, Royal Oak, MI
158. The Increasing Use of Ultrasound Guided Fine Needle Aspiration Biopsy in the
Assessment of Thyroid Lesions: In Search of Optimal Cancer Yield
Carlos Diez Freire, MD, Shahla Masood, MD
University of Florida Health Jacksonville, Jacksonville, FL
159. Correlation Study between Combined Thyroid Imaging Report and Data System (TI-RADS) and
Bethesda System for Thyroid Nodules - An Interventional Cytopathologist’s Experience
Maoxin Wu, MD, PhD
Stony Brook University Hospital, Stony Brook, NY
163. Rapid On-site Evaluation Significantly Reduces Unsatisfactory Rates of Thyroid Ultrasound
Guided Fine-needle Aspiration: A Retrospective Case Control Study
Jessica Tracht, MD, Frida Rosenblum, MD, Erik Kouba, MD, Deepti Bahl, MD, Anish Patel, MD,
Isam-Eldin Eltoum, MD
University of Alabama at Birmingham, Birmingham, AL
164. Thyroid Cysts Comprised of Abundant Mature Squamous Cells can be Reported as Benign:
A Cytologic Study of 18 Patients with Clinical Correlation
Athena Chen, MD1, Andrew Renshaw, MD2, William Faquin, MD, PhD1, Erik Alexander, MD3,
Howard Todd Heller, MD3, Edmund Cibas, MD3
Massachusetts General Hospital, Boston, MA1 Baptist Hospital of Miami, Miami, FL2 Brigham and Women’s Hospital, Boston, MA3
Poster Presentations
University of Texas Medical Branch, Galveston, TX
166. Hurthle Cell Predominance Impacts Results of GEC and Molecular Panel Performance in
Indeterminate Thyroid Nodules
Shobha Parajuli, MD, Rachel Jug, MD, Sara Ahmadi, MD, Xiaoyin Jiang, MD
Duke University Medical Center, Durham, NC
169. The Impact of the Reclassification of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like
Nuclear Features on the Risk of Malignancy Prediction by Fine Needle Aspiration
Nicholas Lau, MD, Andrew Jones, MD, Yanhong Zhang, MD, Michael Campbell, MD, Alaa Afify, MD,
Eric Huang, MD, PhD
University of California, Davis Medical Center, Sacramento, CA
170. Comparison of the Cytologic Features of Non-invasive Follicular Thyroid Neoplasm with
Papillary-like Nuclear Features (NIFTP) to Follicular Variant Papillary Thyroid Carcinoma
Kimberly Point du Jour, MD, PhD, Alessandra Schmitt, MD, Amy Chen, MD, Christopher Griffith, MD, PhD
Emory University, Atlanta, GA
172. Cervical Lymph Node Fine Needle Aspiration and Needle-wash Thyroglobulin Reflex
Test in Papillary Thyroid Carcinoma
Xiaotun Zhang, MD, Joshua Howell, CT(ASCP), Yajue Huang, MD, PhD
Mayo Clinic, Rochester, MN
174. Molecular Mutational Analysis of Indeterminate Thyroid Cytology: A Single Institutional Review
Angela Niehaus, MD, Tracy Justice-Clark, BS, CT(ASCP), Brittany Bohinc Henderson, MD, Simon Bergman, MD
Wake Forest Medical Center, Winston Salem, NC
176. Comparison of Cytologic Findings of BRAF Wild Type and BRAF Mutated Papillary
Thyroid Carcinoma in Conventional Smears
Hongbo Wang, MD, PhD, Wei Zhang, MD, PhD, Deepika Sirohi, MD, Hongxin Fan, MD, Maria Luisa
Policarpio-Nicolas, MD
University of Texas Health Science Center at San Antonio, San Antonio, TX
177. Impact of TyroSeq v2 Testing on the Clinical Management of Patients with Indeterminate
Thyroid Nodules by Fine Needle Aspiration
Roghayeh Fazeli, MD, Huihong Xu, MD, David Kindelberger, MD, Sandra Cerda, MD
Boston University, Boston, MA
180. Digital Image Analysis of Nuclear Morphometry in Thyroid Fine Needle Biopsies
Amin Heidarian, MD, Elham Yousefi, MD, Jonathan Somma, MD
SUNY Downstate Medical Center, Brooklyn, NY
TISSUE/BONE
181. Utility of MDM2, p16, HMB-45 and Melan A Immunohistochemistry in Differentiating
Angiomyolipoma from Well-Differentiated Liposarcoma
Xiaoqi Lin, MD, PhD1, William Laskin, MD2, Yaxia Zhang, MD, PhD3
Northwestern University, Chicago, IL1 Yale University, New Haven, CT2 Cleveland Clinic, Cleveland, OH3
182. Angiosarcoma: Review of Cytologic Features and ERG Staining in Six Patients
Adriana Sanchez, MD, Nour Yadak, MD, Therese Bocklage, MD
University of New Mexico, Albuquerque, NM
OTHER
183. Molecular Tumor Classification of Cytopathology Specimens in Metastatic Cancer
Harris Soifer, PhD1, Barbara Centeno, MD2, Max Salganik, PhD1, Catherine Schnabel, PhD1
Biotheranostics, Inc., San Diego, CA1 Moffitt Cancer Center, Tampa, FL2
Schedule
Sara E. Monaco, MD
2017 CaseatHistories
cytopathologymeeting.org/2017/diagnostic Christopher J. VandenBussche, MD, PhD
Sean A. McNair, MPH, CT(ASCP)
a Glance
88 year-old woman. LMP: PM. Patient presented with a vaginal mass and post-menopausal
bleeding. ThinPrep Pap Test slide.
My Diagnosis:
Panels Diagnosis:
Final Diagnosis:
55 year-old male with multiple lung masses. History of head and neck cancer. The largest
is 9 cm, involving lung, chest wall, and rib. The slides are from a transbronchial FNA of the
chest wall mass.
My Diagnosis:
Panels Diagnosis:
Final Diagnosis:
45 year-old female with a 3.5 cm submandibular mass. History of renal failure on dialysis,
no history of malignancy. The slide is from an FNA of the submandibular mass.
My Diagnosis:
Panels Diagnosis:
Final Diagnosis:
47 year-old female with a prominent right axillary lymph node, s/p incision and drainage of a
right axillary abscess 9 months ago. The slides are from an FNA of the right axillary lymph node.
My Diagnosis:
Panels Diagnosis:
Final Diagnosis:
Schedule
2017 CaseatHistories
carcinoma with lymph node metastasis. Slides are from ThinPrep (Pap Stain) and FNA smear
(Pap stain) of zone 5 cervical lymph node on the right side of the neck.
My Diagnosis:
a Glance
Panels Diagnosis:
Final Diagnosis:
82 year old male with multiple liver masses. History of prostate cancer. The slides are from an
FNA (Diff Quik) and touch prep (Pap) of a liver mass.
My Diagnosis:
Panels Diagnosis:
Final Diagnosis:
59 year-old male with solitary liver mass and an ill-defined possible pancreatic mass.
The slides are from an EUS-guided FNA of the liver mass.
My Diagnosis:
Panels Diagnosis:
Final Diagnosis:
54 year-old male with a lytic mass of right acromion. The slides are from an FNA of the mass.
My Diagnosis:
Panels Diagnosis:
Final Diagnosis:
Platinum Level
Gold Level
FOUNDATION
FIGHTING C ANCER
SAVING LIVES
Friend
Patron
FOUNDATION
FIGHTING C ANCER
SAVING LIVES
In Kind Contributions
Levels of Support
2017 Exhibitors
www.ascp.org
Membership benefits:
• The Voice newsletter
• Continuing education opportunities:
Webinars on current topics
Quality Assessment Workbenches
Annual conference offering CE
Updated Introduction to the Cytopreparation Laboratory online
course
• “Ask ASCT”: resource of knowledge on hot topics from members
• Member directory
• Discounted rates on conference registrations, publications, merchandise
• Career Center
www.asct.com
2017 Exhibitors
maintains continued focuses to bring the highest quality solutions.
Those solutions are designed to not only improve patient care, but
enhance our Lab partners experience. By providing a high quality,
low cost, efficient and dependable solutions we bring long lasting
value to all of our customers.
• Forward Innovation: Current R&D is focused on New NON-GYN
computer aided diagnostic systems for higher throughput while
generating more accurate diagnoses
• Our R&D’s New SureCyte PLUS Biomarker is first-of-its-kind with
ability to risk assess various types of cancers
• NEW: Our SureThin LBC Processors and Filters, Vials and tools offer
high efficacy at prices well under current market conditions.
www.medite-group.com
2017 Exhibitors
Supply) mounted directly onto an easy to roll cart. Live-dynamic HD
video is streamed to remote pathologists, to PC’s, Mac’s™, iPhones™,
iPads™, and Android™ devices from any room the cart is located. This
mobile solution has been proven to enhance workflow efficiencies.
www.rmtcentral.com
20'
300
20'
200
20'
73
Which
Which
Which
HPV
HPV
HPV
test
test
test
is right
is is
right
right
for for
which
for
which
which
patients?
patients?
patients?
cobas
cobas
—cobas
the—only
the
— the
only
oneonly
for
oneone
all.
for for
all.all.
More screening
MoreMore
screening
screening
options
options
foroptions
more
forpatients.
more
for more
patients.
patients.
The cobas
The HPV
cobas
The Test
cobasHPV
is approved
HPV
Test is Test
approved
for
is approved
the broadest
for the
forbroadest
the broadest
intendedintended
useintended
for use
HPVfor use
testing
HPV
for HPVtesting
in cervical
testing
in cervical
cancer
in cervical
cancer
cancer
screening. 1
Whether
screening.
screening.
1
Whether
youWhether
1
co-test,
you co-test,
you
genotype,
co-test,
genotype,
genotype,
ASC-USASC-US
reflASC-US
ex orrefl
primary
exrefl
orexprimary
screen,
or primaryscreen,
we doscreen,
itwe
all.do
weitdo
all.it all.
So, clinicians
So, clinicians
So,
can
clinicians
be confi
can becan
dent confi
bethey’re
confi
dent dent
providing
they’re
they’re
providing
providing
the bestthe
carebest
the
forbest
care
all ofcare
for
their
allforof
patients,
all
their
of their
patients,
andpatients,
youandcanyou
and can
you can
be confibe
dent
confi
beyou’re
confi
dentdent
offering
you’reyou’re
offering
theoffering
mosttheapproved
most
the mostapproved
approved
optionsoptions
available.
options
available.
available.
To learnTomore,
learn
To learn
visit
more,www.TheOnlyOneForAll.com.
more,
visit visit
www.TheOnlyOneForAll.com.
www.TheOnlyOneForAll.com.
cobas—the
cobas—the
cobas—the
only HPV
onlyscreening
only
HPVHPVscreening
screening
assay assayassay
to cover
to cover
ALL
to cover
options
ALLALL
options
outlined
options
outlined
inoutlined
the in the
in the
2016 ACOG
20162016
ACOG
Practice
ACOGPractice
Bulletin
Practice
Bulletin
Bulletin
cobas® HPV
1. cobas®
Test1.[package
cobas®
HPV Test
insert].
HPV
[package
TestIndianapolis,
[package
insert]. Indianapolis,
insert].
IN: RocheIndianapolis,
Diagnostics;
IN: RocheIN:Diagnostics;
2014.
Roche Diagnostics;
2014. 2014.
OBAS and COBAS
LIFE NEEDS
COBAS
and LIFE
ANSWERS
and
NEEDS
LIFEare
NEEDS
ANSWERS
trademarks
ANSWERS
are of
trademarks
Roche.
are trademarks
of Roche.of Roche.
2016 Roche.
© 2016
PP-US-05706-0216
©
Roche.
2016 PP-US-05706-0216
Roche. PP-US-05706-0216
oche Diagnostics
Roche Diagnostics
9115
Roche Hague
Diagnostics
Road,
9115 Hague
Indianapolis,
9115 Road,
HagueIndianapolis,
IN
Road,
46256Indianapolis,
IN 46256 IN 46256
ASC Foundation
One can never say thank you too much or too often for the
gift of mentorship—those who have contributed time and
expertise to benefit others. With a gift of any size to the
Foundation, you can make a star of your Mentor and give
them a special place in our galaxy.
Amethyst Sapphire
For each honored colleague. A colleague honored by five or more people.
Ruby Emerald
A colleague honored in two or A colleague honored with donations
more consecutive years. totaling $500 or more.
Current ACCME guidelines state that participants in CME activities should be made aware of
any affiliation or financial interest that may affect the speaker’s presentation(s). Therefore,
it is the policy of the American Society of Cytopathology to insure balance, independence,
objectivity, and scientific rigor in all its educational programs. All planning individuals
participating in any ASC Educational Activity are expected to disclose to the program
audience any real or apparent conflict(s) of interest that may have a direct bearing on the
subject matter of the continuing education program. This pertains to relationships with
any entity producing, marketing, reselling, or distributing health care goods or services
consumed by, or used on, patients. The intent of this policy is not to prevent a speaker with
a potential conflict of interest from making a presentation. It is merely intended that any
potential conflict should be identified openly so that the listener may form his own judgment
about the presentation with the full disclosure of the facts. It remains for the audience to
determine whether the speaker’s outside interests may reflect a possible bias in either the
exposition or the conclusions presented.
All participants involved in developing this educational activity, including Scientific Program
Committee Members, Continuing Education Oversight Committee Members, Executive Board
Members, ASC National Office Staff and scheduled speakers have been asked to identify
potential conflicts.
Speaker Disclosure
Deborah A. Hillsdon-Smith, MBA, LSSBB, SCT(ASCP) Employee relationship with Roche Diagnostics
Roche Diagnostics, Inc.
Granger, IN
Roundtable Discussion 03
Speaker Disclosure
Meeting Faculty
Non-Microscopic Workshop 15
Meeting Faculty
Brigham & Women’s Hospital Chapel Hill, NC
Boston, MA Video Microscopy Tutorial 07 & 09
State of the Society
Executive Board Sandra Dolar, BA, SCT(ASCP)
Cleveland Clinic
Douglas P. Clark, MD Cleveland, OH
University of New Mexico Strategies in Cytotechnology Education
Albuquerque, NM
Cytology Shark Tank Amber D. Donnelly, PhD, MPH, SCT(ASCP)
University of Nebraska Medical Center
Amy C. Clayton, MD Omaha, NE
Mayo Clinic and Foundation The Evolution of Cytopathology Practice
Rochester, MN Executive Board
Executive Board Strategies in Cytotechnology Education
Meeting Faculty
San Francisco, CA Baltimore, MD
Current Issues in Cytology Non-Microscopic Mini Workshop 02
Lisa Ring, SCT(ASCP), MB, HTLCM Lynnette Savaloja Pineault, MBA, SCT(ASCP)
Massachusetts General Hospital Regions Hospital
Boston, MA Saint Paul, MN
Current Issues in Cytology The Evolution of Cytopathology Practice
Meeting Faculty
Birmingham, AL Houston, TX
State of the Society Sign-out with the Professor 09
The Evolution of Cytopathology Practice Executive Board
Executive Board
Rudy Schwenk, MD
Michael H. Roh, MD, PhD CENTA/CAMP Labs
Mayo Clinic Indianapolis, IN
Rochester, MN Scientific Program Committee
Diagnostic Cytology Seminar
Deborah Sheldon
Dorothy L. Rosenthal, MD, FIAC ASC National Office
The Johns Hopkins Hospital Wilmington, DE
Baltimore, MD ASC National Office Staff
Sign-out with the Professor 10
Amber L. Smith, MD
Susan Rollins, MD MD Anderson Cancer Center
Outpatient Cytopathology Center Houston, TX
Johnson City, TN Platform Presentation 01
Trainee Enrichment 03
Ultrasound Course Michele A. Smith, MS, SCT(ASCP)
Roundtable Discussion 05 Wisconsin State Laboratory of Hygiene
Madison, WI
Esther Diana Rossi, MD, PhD, MIAC Scientific Program Committee
Catholic University
Rome, Italy Paul N. Staats, MD
Platform Presentation 11 University of Maryland School of Medicine
State of the Art Symposium Baltimore, MD
Diagnostic Cytology Seminar
Donna K. Russell, MEd, CT(ASCP)HT Non-Microscopic Workshop 12
University of Rochester Medical Center
Rochester, NY Charles D. Sturgis, MD
Virtual Slide Seminar 04 & 07 Cleveland Clinic
Video Microscopy Tutorial 02 Cleveland, OH
Platform Presentation 04 Panel Luncheon Seminar 04
Non-Microscopic Workshop 13
Mauro A. Saieg, MD, PhD, MIAC
Santa Casa Medical School Eric J. Suba, MD
Sao Paulo, Brazil Kaiser Permanente Medical Center
Platform Presentation 02 San Francisco, CA
Disparities in Healthcare
Marcela Salomao, MD
Mayo Clinic Wei Sun, MD
Scottsdale, AZ New York University Medical Center
Microscopic Workshop 04 New York, NY
Microscopic Workshop 03
Anjali N. Saqi, MD, MBA
Columbia University Medical Center Kaitlin Sundling, MD, PhD
New York, NY University of Wisconsin
Current Issues in Cytology Madison, WI
Microscopic Workshop 04 Non-Microscopic Workshop 12
Non-Microscopic Workshop 02
Available at cytopathologymeeting.org
Online
Schedule
The ASC is using Online Credit System Information
Tracking and Evaluations for the • To login, you need your email address
and your badge number on the front of
65th Annual Scientific Meeting.
Credit
your name badge or ASC Member login.
• Details for using the system are online.
at aTracking
Please use the following worksheets • You must complete the evaluation of a
to track your credit hours for ease in session to receive credit for the session.
Glance
claiming credits online. • Self-Assessment Modules (SAMs) and
CME are available for physicians, along
The site will be available, including with CMLE for cytotechnologists.
handouts, DURING and for 30 days • It is not necessary to complete your
AFTER the Annual Scientific Meeting evaluation in one sitting – the system
and can be accessed onsite using the will save your entries.
terminals in the Cyber Café or from • The system allows you to email yourself
any web browser at any time. a certificate after completion, instead
of returning to the site at a later date
to print.
ASC Members have the capability
• Your certificate fulfills CME/CMLE or
to track all ASC educational credits SAM, if the post-test is completed.
from year to year.
Available at cytopathologymeeting.org
Online
SAM
Schedule
Soft Tissue Tumors that Mimic Carcinomas
Non-Microscopic
NWK03 in Fine Needle Aspiration: Pearls and 1.5
Workshop
Pitfalls
Credit
Thyroid Cytopathology: Meeting the Sign-out with the
MHSP04 1
Challenge Professor
at aTracking
Fine-needle Aspiration Cytology of Salivary
Non-Microscopic
NWK04 Gland Lesions: A Novel Practical Pattern 1.5
Workshop
Glance
Based Approach to Diagnosis
Distinguishing NIFTP and Other Benign
and Malignant Look-alike Thyroid
MWK03 Microscopic Workshop 2
Lesions by Ultrasound and Cytology with
Histologic Correlation
How to Stand Out in a Crowd: Video Microscopy
VMT02 1.5
Differentiating Hyperchromatic Groups Tutorial
Challenging Cases in Thyroid Cytology:
Video Microscopy
VMT03 Striving to Minimize the Indeterminate 1.5
Tutorial
Categories
*Note: Sessions in turquoise are SAM eligible. You must choose to claim these sessions as SAM or CME.
Available at cytopathologymeeting.org
Available at cytopathologymeeting.org
Online
SAM
Schedule
Combining Recent Medical Technology
Roundtable
RT11 Advances and Rapid On-site Evaluation to 1.75
Discussion
Optimize Patient Centered Practice
Credit
Pancreatobiliary Cytology and
Small Biopsies: Morphology,
at aTracking
MWK04 Immunohistochemistry, Molecular Testing Microscopic Workshop 2
and Specimen Triage for Optimizing
Diagnosis
Glance
Diagnostically Challenging Core Biopsy
VSS02 and Fine Needle Aspiration Cytology: How Virtual Slide Seminar 2
Much Can We Offer?
Breast FNA Biopsy with a Focus on Video Microscopy
VMT04 1.5
Papillary Lesions Tutorial
Sign-out with the
MHSP06 Selected Challenges in Salivary Gland 1
Professor
Enhancing Your Image: Newer Tools and Panel Luncheon
PL01 1.75
Concepts to Work with Electronic Images Seminar
Papanicolaou Society of Cytopathology
Pancreaticobiliary Guidelines: Update Panel Luncheon
PL02 1.75
on Pancreatic Cystic Lesions and Duct Seminar
Brushing Specimens
Uncommon and Interesting Cases in
Sign-out with the
MHSP07 Gynecologic Cytology and How to Resolve 1
Professor
Them
Whole Slide Imaging in Cytopathology:
Non-Microscopic Mini
NWKM03 Current Applications And Future 1
Workshop
Directions
Three-dimensional Cytology: A Tour of the
Video Microscopy
VMT05 Lung - Normal, Reactive, Dysplasia, and 1.5
Tutorial
Cancer
Challenging Hematopathology Cases in
Non-Microscopic
NWK06 FNA and Small Biopsies: Lesions other than 1.5
Workshop
Non-Hodgkin Lymphoma
Challenging Diff-Quik Adequacy Cases in
VSS03 Virtual Slide Seminar 2
the Bronchoscopy Suite Session One
How to Sign-out Pancreatic Cysts on Sign-out with the
MHSP08 1
EUS-FNA Professor
Thyroid Hurthle Cell Lesions: Challenges Video Microscopy
VMT06 1.5
and Pitfalls in Classification Tutorial
*Note: Sessions in turquoise are SAM eligible. You must choose to claim these sessions as SAM or CME.
Available at cytopathologymeeting.org
Available at cytopathologymeeting.org
Online
Session Max
Session Title Session Type CMLE
Schedule
Code Credits
SAM
Cancer Screening, Current Concepts for Panel Luncheon
PL04 1.75
Everyone, an LGBT Focus Seminar
Credit
Cytology & Beyond: Molecular and Ancillary
at aTracking
Panel Luncheon
PL03 Test Correlations for Head and Neck 1.75
Seminar
Neoplasms
Glance
Difficult Diagnoses in EUS Fine Needle Sign-out with the
MHSP11 1
Aspiration Professor
Non-Microscopic
NWK13 Cerebrospinal Fluid: A Bath for Your Brain 1.5
Workshop
*Note: Sessions in turquoise are SAM eligible. You must choose to claim these sessions as SAM or CME.
Available at cytopathologymeeting.org
Additional Sessions
The Role of the Cytopathologist in the
Measurement of Circulating Tumor Cells Non-Microscopic
NWK10 1.5
(CTCs) Using the CellSearch System and Workshop
Review of New Technologies
*Note: Sessions in turquoise are SAM eligible. You must choose to claim these sessions as SAM or CME.
Available at cytopathologymeeting.org
Interact with Colleagues. The ASC is a Join the Discussion. ASC members have
unique society that provides a forum where exclusive access to the ASC Listserv. Instantly
pathologists and cytotechnologists can interact connect with fellow ASC members to network,
and network with each other on personal and share professional experiences or discuss issues
professional levels. related to the field of cytopathology.
Members Only Access. Your Members Only Contribute to the Future Success of
access allows you to search the membership Cytopathology. Your membership to the ASC
directory, access Case Studies and eJournals for signifies your commitment to the ongoing
free, join Committees, register for educational enhancement and awareness of the field of
activities at reduced member rates, and search cytopathology. The ASC monitors national
for job opportunities. recruitment issues and keeps abreast of
legislative issues relating to the field of
pathology. In addition, the ASC provides
Become a memBer today liaisons to major national and international
medical and pathology related organizations
cytopathology.org ensuring your voice is represented on decisions
that matter most to your profession.
Schedule
Notes
at a Glance
Schedule
Notes
at a Glance
Schedule
Notes
at a Glance
Make a Note of ASC Future Meetings
November 10 -13, 2018
Omni Shoreham Hotel
Washington, D.C.
Oasis
Meeting
Room
Oasis
Vista Meeting Lawn
Room & Terrace
Th
e
Vi
lla
s
Oasis
Pool
Island Green
Event Lawn
N
Oasis
Bar
by
G
ob
ra
n
tL
d
or
kw
ay
Camelback Sedona
Guest Rooms Guest Rooms
Fountain Circle
Camelback Conference Sedona Conference
Suites (10) Suites (18)
ay
Camelback C, Level 3
kw
W
al Sedona D, Level 4
al
kw
W
Camelback D, Level 4 ay
Camelback F, Level 6 South
Mountain Patio
South Mountain
Ballroom
Mesquite
Lantana
Kaibab
Noble
Paseo
N
K
M
L
West
Arizona Grand
Ballroom Sunset
G J Patio
Goldwater Juniper
Sierra
Ballroom
F I
ay
Foxtail Ironwood 1 2 3
kw
al
W
Palm
W Court
A ack
al
kw E H
Plaza
elb
ay
Camelback Eucalyptus Honeysuckle
Cam
Patio
Sonoran
Bougainvillea
Desert Willow
Patio
Copperwood
Acacia
3
D
C
A
Paseo y
Sk
2
East
an m Bu
or lroo Ce sin
1
n l nt es
So Ba
2 lm
er s Map Legend
Pa
Pa D
4
Ballroom Foyer
2C lm
2A lm
Ocotillo Ocotillo
Pa
A B 1st Level
2B lm
Pa alm
2
Pa
5
tio
6
Reg Reg
P
Office Office
3rd Level
Grand Veranda
8
Patios
Pa 3D
3A lm
lm
Pa
Pa 3C
3B lm
lm
Palm 3 Patio
Pa
Las Palmas
ROUNDS R
ENT VENUES RECEPTION OUTDOOR EVENT VENUES
OF 10
COMING SOON
The ThinPrep Integrated Imager is not available for sale in the U.S.
ADS-01586-001 Rev. 003 Rev. 001 © 2017 Hologic, Inc. All rights reserved.
Hologic, The Science of Sure, ThinPrep and associated logos are trademarks
and/or registered trademarks of Hologic, Inc. and/or its subsidiaries in the
United States and/or other countries.